In mice, loss of SOCS2 biases towards CD4+ Th2 differentiation, suggesting patients with allergic diseases such as atopic dermatitis and asthma may benefit from enhanced SOCS2 expression or activity27. This evidence concerns the gene CD4 and atopic eczema.